David Dunaway, MD
Dermatology · Jenkintown, PANPI 1619321619
Payments from drug & device makers
Across 544 payments — averaging $104.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$45K
- Regeneron Healthcare Solutions, Inc.$3K
- Johnson & Johnson$2K
- Sun Pharmaceutical Industries Inc.$1K
- Sanofi$849
- Novartis$645
- plus $4K from 23 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 168 | $45,495 |
| Regeneron Healthcare Solutions, Inc. | 34 | $3,188 |
| Johnson & Johnson | 100 | $2,011 |
| Sun Pharmaceutical Industries Inc. | 25 | $1,174 |
| Sanofi | 32 | $849 |
| Novartis | 32 | $645 |
| Lilly USA, LLC | 32 | $635 |
| Incyte Corporation | 19 | $511 |
| Janssen Scientific Affairs, LLC | 4 | $392 |
| Galderma Laboratories, L.p. | 18 | $366 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $316 |
| E.r. Squibb & Sons, L.L.C. | 13 | $242 |
| Amgen | 7 | $152 |
| Organon | 4 | $100 |
| Strata Skin Sciences, Inc. | 6 | $96 |
| LEO Pharma Inc. | 5 | $92 |
| Pfizer | 5 | $90 |
| Arcutis Biotherapeutics, Inc. | 5 | $89 |
| Almirall LLC | 4 | $82 |
| Paratek Pharmaceuticals, Inc. | 4 | $79 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $75 |
| Sanofi-aventis U.S. LLC | 1 | $69 |
| Dermavant Sciences, Inc. | 3 | $59 |
| UCB, Inc. | 1 | $36 |
| Botanix SB Inc | 2 | $30 |
| Genentech USA, Inc. | 1 | $21 |
| EPI Health, LLC | 1 | $16 |
| Journey Medical Corporation | 1 | $14 |
| Mission Pharmacal Company | 1 | $13 |
How this compares
$56,937 in reported general payments places this provider in the 90th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Jenkintown
- Victoria WerthPhiladelphia$7.2M
- Laura FerrisPittsburgh$4.3M
- Joel GelfandPhiladelphia$3.6M
- Scott GottliebExton$3.4M
- Lawrence ParishPhiladelphia$2.9M
- Stephen SchleicherSugarloaf$2.3M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Joe TungPittsburgh$1.5M
- Joslyn Sciacca-KirbyHershey$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.